Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy

Published:March 18, 2013DOI:


      Background & aims

      Green tea catechins, especially epigallocatechin-3-gallate (EGCG), have been associated with cancer prevention and treatment. This has resulted in an increased number of studies evaluating the effects derived from the use of this compound in combination with chemo/radiotherapy. This review aims at compiling latest literature on this subject.


      Keywords including EGCG, cancer, chemotherapy, radiotherapy and side effects, were searched using PubMed and ScienceDirect databases to identify, analyze, and summarize the research literature on this topic. Most of the studies on this subject up to date are preclinical. Relevance of the findings, impact factor, and date of publication were critical parameters for the studies to be included in the review.


      Additive and synergistic effects of EGCG when combined with conventional cancer therapies have been proposed, and its anti-inflammatory and antioxidant activities have been related to amelioration of cancer therapy side effects. However, antagonistic interactions with certain anticancer drugs might limit its clinical use.


      The use of EGCG could enhance the effect of conventional cancer therapies through additive or synergistic effects as well as through amelioration of deleterious side effects. Further research, especially at the clinical level, is needed to ascertain the potential role of EGCG as adjuvant in cancer therapy.



      5-FU (5-fluorouracil), ATO (arsenic trioxide), CP (cisplatin), DNR (daunorubicin), DNROL (daunorubicinol), DOX (doxorubicin), EGCG (epigallocatechin-3-gallate), HBMEC (human brain microvascular endothelial cells), HRPC (hormone refractory prostate cancer), HNE (hydroxynonenal), IL (interleukin), IR (ionizing radiation), ROS (reactive oxygen species), TSA (trichostatin A)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Yang C.S.
        • Wang H.
        • Li G.X.
        • Yang Z.
        • Guan F.
        • Jin H.
        Cancer prevention by tea: evidence from laboratory studies.
        Pharmacol Res. 2011; 64: 113-122
        • Singh B.N.
        • Shankar S.
        • Srivastava R.K.
        Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
        Biochem Pharmacol. 2011; 82: 1807-1821
        • Suganuma M.
        • Saha A.
        • Fujiki H.
        New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
        Cancer Sci. 2011; 102: 317-323
        • Wessner B.
        • Strasser E.M.
        • Koitz N.
        • Schmuckenschlager C.
        • Unger-Manhart N.
        • Roth E.
        Green tea polyphenol administration partly ameliorates chemotherapy-induced side effects in the small intestine of mice.
        J Nutr. 2007; 137: 634-640
        • Qiao J.
        • Gu C.
        • Shang W.
        • Du J.
        • Yin W.
        • Zhu M.
        • et al.
        Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
        Food Chem Toxicol. 2011; 49: 1410-1415
        • Stearns M.E.
        • Amatangelo M.D.
        • Varma D.
        • Sell C.
        • Goodyear S.M.
        Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
        Am J Pathol. 2010; 177: 3169-3179
        • Liang G.
        • Tang A.
        • Lin X.
        • Li L.
        • Zhang S.
        • Huang Z.
        • et al.
        Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
        Int J Oncol. 2010; 37: 111-123
        • Farabegoli F.
        • Papi A.
        • Bartolini G.
        • Ostan R.
        • Orlandi M.
        (−)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
        Phytomedicine. 2010; 17: 356-362
        • Stearns M.E.
        • Wang M.
        Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors.
        Transl Oncol. 2011; 4: 147-156
        • Nihal M.
        • Roelke C.T.
        • Wood G.S.
        Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (−)-epigallocatechin-3-gallate (EGCG).
        Pharm Res. 2010; 27: 1103-1114
        • Mohan N.
        • Karmakar S.
        • Banik N.L.
        • Ray S.K.
        SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
        Neurochem Res. 2011; 36: 1383-1396
        • Tang S.N.
        • Fu J.
        • Shankar S.
        • Srivastava R.K.
        EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.
        PLoS One. 2012; 7: e31067
        • Huang K.H.
        • Kuo K.L.
        • Chen S.C.
        • Weng T.I.
        • Chuang Y.T.
        • Tsai Y.C.
        • et al.
        Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
        PLoS One. 2012; 7: e33615
        • Bachmeier B.
        • Fichtner I.
        • Killian P.H.
        • Kronski E.
        • Pfeffer U.
        • Efferth T.
        Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.
        PLoS One. 2011; 6: e20550
        • Chen T.C.
        • Wang W.
        • Golden E.B.
        • Thomas S.
        • Sivakumar W.
        • Hofman F.M.
        • et al.
        Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
        Cancer Lett. 2011; 302: 100-108
        • Luo T.
        • Wang J.
        • Yin Y.
        • Hua H.
        • Jing J.
        • Sun X.
        • et al.
        (−)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.
        Breast Cancer Res. 2010; 12: R8
        • Huang W.
        • Ding L.
        • Huang Q.
        • Hu H.
        • Liu S.
        • Yang X.
        • et al.
        Carbonyl reductase 1 as a novel target of (−)-epigallocatechin gallate against hepatocellular carcinoma.
        Hepatology. 2010; 52: 703-714
        • Tu S.H.
        • Ku C.Y.
        • Ho C.T.
        • Chen C.S.
        • Huang C.S.
        • Lee C.H.
        • et al.
        Tea polyphenol (−)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells.
        Mol Nutr Food Res. 2011; 55: 455-466
        • Farabegoli F.
        • Barbi C.
        • Lambertini E.
        • Piva R.
        (−)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.
        Cancer Detect Prev. 2007; 31: 499-504
        • Li Y.
        • Yuan Y.Y.
        • Meeran S.M.
        • Tollefsbol T.O.
        Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells.
        Mol Cancer. 2010; 9: 274
        • Chuu C.P.
        • Chen R.Y.
        • Kokontis J.M.
        • Hiipakka R.A.
        • Liao S.
        Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
        Cancer Lett. 2009; 275: 86-92
        • Siddiqui I.A.
        • Asim M.
        • Hafeez B.B.
        • Adhami V.M.
        • Tarapore R.S.
        • Mukhtar H.
        Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.
        FASEB J. 2011; 25: 1198-1207
        • Lambert J.D.
        • Elias R.J.
        The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention.
        Arch Biochem Biophys. 2010; 501: 65-72
        • Chan M.M.
        • Soprano K.J.
        • Weinstein K.
        • Fong D.
        Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.
        J Cell Physiol. 2006; 207: 389-396
        • Lee T.C.
        • Cheng I.C.
        • Shue J.J.
        • Wang T.C.
        Cytotoxicity of arsenic trioxide is enhanced by (−)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells.
        Toxicol Appl Pharmacol. 2011; 250: 69-77
        • Hwang J.T.
        • Ha J.
        • Park I.J.
        • Lee S.K.
        • Baik H.W.
        • Kim Y.M.
        • et al.
        Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.
        Cancer Lett. 2007; 247: 115-121
        • Bannerman B.
        • Xu L.
        • Jones M.
        • Tsu C.
        • Yu J.
        • Hales P.
        • et al.
        Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
        Cancer Chemother Pharmacol. 2011; 68: 1145-1154
        • Ge J.
        • Tan B.X.
        • Chen Y.
        • Yang L.
        • Peng X.C.
        • Li H.Z.
        • et al.
        Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability.
        J Mol Med (Berl). 2011; 89: 595-602
        • McLaughlin N.
        • Annabi B.
        • Bouzeghrane M.
        • Temme A.
        • Bahary J.P.
        • Moumdjian R.
        • et al.
        The survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (−)-epigallocatechin-3-gallate.
        Brain Res. 2006; 1071: 1-9
        • Baatout S.
        • Jacquet P.
        • Derradji H.
        • Ooms D.
        • Michaux A.
        • Mergeay M.
        Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.
        Oncol Rep. 2004; 12: 159-167
        • McLaughlin N.
        • Annabi B.
        • Lachambre M.P.
        • Kim K.S.
        • Bahary J.P.
        • Moumdjian R.
        • et al.
        Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.
        J Neurooncol. 2006; 80: 111-121
        • Zhang G.
        • Wang Y.
        • Zhang Y.
        • Wan X.
        • Li J.
        • Liu K.
        • et al.
        Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
        Curr Mol Med. 2012; 12: 163-176
        • Lee H.J.
        • Kim J.S.
        • Moon C.
        • Kim J.C.
        • Lee Y.S.
        • Jang J.S.
        • et al.
        Modification of gamma-radiation response in mice by green tea polyphenols.
        Phytother Res. 2008; 22: 1380-1383
        • Abboud P.A.
        • Hake P.W.
        • Burroughs T.J.
        • Odoms K.
        • O'Connor M.
        • Mangeshkar P.
        • et al.
        Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.
        Eur J Pharmacol. 2008; 579: 411-417
        • Sergent T.
        • Piront N.
        • Meurice J.
        • Toussaint O.
        • Schneider Y.J.
        Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium.
        Chem Biol Interact. 2010; 188: 659-667
        • Hu Y.
        • Cao J.J.
        • Liu P.
        • Guo D.H.
        • Wang Y.P.
        • Yin J.
        • et al.
        Protective role of tea polyphenols in combination against radiation-induced haematopoietic and biochemical alterations in mice.
        Phytother Res. 2011; 25: 1761-1769
        • Li W.
        • Ashok M.
        • Li J.
        • Yang H.
        • Sama A.E.
        • Wang H.
        A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1.
        PLoS One. 2007; 2: e1153
        • Annabi B.
        • Lee Y.T.
        • Martel C.
        • Pilorget A.
        • Bahary J.P.
        • Beliveau R.
        Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (−) epigallocatechin-3-gallate.
        Cancer Biol Ther. 2003; 2: 642-649
        • Alcaraz M.
        • Armero D.
        • Martinez-Beneyto Y.
        • Castillo J.
        • Benavente-García O.
        • Fernandez H.
        • et al.
        Chemical genoprotection: reducing biological damage to as low as reasonably achievable levels.
        Dentomaxillofac Radiol. 2011; 40: 310-314
        • Pajonk F.
        • Riedisser A.
        • Henke M.
        • McBride W.H.
        • Fiebich B.
        The effects of tea extracts on proinflammatory signaling.
        BMC Med. 2006; 4: 28
        • Khan S.A.
        • Priyamvada S.
        • Khan W.
        • Khan S.
        • Farooq N.
        • Yusufi A.N.
        Studies on the protective effect of green tea against cisplatin induced nephrotoxicity.
        Pharmacol Res. 2009; 60: 382-391
        • Sahin K.
        • Tuzcu M.
        • Gencoglu H.
        • Dogukan A.
        • Timurkan M.
        • Sahin N.
        • et al.
        Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.
        Life Sci. 2010; 87: 240-245
        • El-Mowafy A.M.
        • Al-Gayyar M.M.
        • Salem H.A.
        • El-Mesery M.E.
        • Darweish M.M.
        Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling.
        Phytomedicine. 2010; 17: 1067-1075
        • Li W.
        • Nie S.
        • Xie M.
        • Chen Y.
        • Li C.
        • Zhang H.
        A major green tea component, (−)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats.
        J Agric Food Chem. 2010; 58: 8977-8982
        • Zheng J.
        • Lee H.C.
        • Bin Sattar M.M.
        • Huang Y.
        • Bian J.S.
        Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury.
        Eur J Pharmacol. 2011; 652: 82-88
        • Schmitt N.C.
        • Rubel E.W.
        • Nathanson N.M.
        Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.
        J Neurosci. 2009; 29: 3843-3851
        • Peng Z.
        • Xu Z.W.
        • Wen W.S.
        • Wang R.S.
        Tea polyphenols protect against irradiation-induced injury in submandibular glands' cells: a preliminary study.
        Arch Oral Biol. 2011; 56: 738-743
        • Yamamoto T.
        • Staples J.
        • Wataha J.
        • Lewis J.
        • Lockwood P.
        • Schoenlein P.
        • et al.
        Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride.
        Anticancer Res. 2004; 24: 3065-3073
        • Sriram N.
        • Kalayarasan S.
        • Sudhandiran G.
        Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
        Chem Biol Interact. 2009; 180: 271-280
        • Sriram N.
        • Kalayarasan S.
        • Sudhandiran G.
        Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.
        Pulm Pharmacol Ther. 2009; 22: 221-236